This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Asano, Y. Articles by Niho, Y. Search for Related Content PubMed PubMed Citation Articles by Asano, Y. Articles by Niho, Y.

Effect of the Chimeric Soluble Granulocyte Colony-stimulating Factor Receptor on the Proliferation of Leukemic Blast Cells from Patients with Acute Myeloblastic Leukemia¹

The First Department of Internal Medicine, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku. Fukuoka 812-82, Japan

The biological roles of the soluble granulocyte colony-stimulating factor (G-CSF) receptor, which arises as a result of alternative RNA splicing, are as yet unknown. In this study, we examined the in vitro effect of a chimeric protein composed of the extracellular region of a murine G-CSF receptor and the human IgG1 Fc region because a human natural soluble G-CSF receptor was not available. First, we found that this chimeric soluble G-CSF receptor could inhibit the biological activity of G-CSF on normal bone marrow colony formation. Because G-CSF also plays an important role in the proliferation of leukemic blast cells, we next examined the effect of the soluble G-CSF receptor on leukemic blast colony formation in 10 acute myeloblastic leukemia cases. Although G-CSF stimulated the proliferation of leukemic progenitor cells to form leukemic blast colonies, the chimeric soluble G-CSF receptor completely inhibited this stimulatory effect. Furthermore, the chimeric soluble G-CSF receptor also inhibited spontaneous leukemic blast colony formation in two cases. Because a high concentration of G-CSF was observed in the supernatants of leukemic blast cells from these two cases, it seems likely that the soluble G-CSF receptor cut off the autocrine growth mechanism of leukemic blast cells mediated by G-CSF. These findings suggest the possibility that the soluble G-CSF receptor could be used in a clinical application for acute myelo-blastic leukemia patients in the future.

¹ This work was supported by Grants-in-Aid 08261211, 09250211, and 09255241 from the Ministry of Education, Science, Sports and Culture of Japan and by the Foundation for the Advancement of Clinical Medicine.

² To whom requests for reprints should be addressed. Phone: 81-92-642-5230; Fax: 81-92-642-5247.

Received 1/ 3/97. Accepted 6/18/97.

This article has been cited by other articles:

				S. N. Prince, E. J. Foulstone, O. J. Zaccheo, C. Williams, and A. B. Hassan Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor Mol. Cancer Ther., February 1, 2007; 6(2): 607 - 617. [Abstract] [Full Text] [PDF]

				H. Iwasaki, K. Shimoda, S. Okamura, T. Otsuka, K. Nagafuji, N. Harada, Y. Ohno, T. Miyamoto, K. Akashi, M. Harada, et al. Production of Soluble Granulocyte Colony-Stimulating Factor Receptors from Myelomonocytic Cells J. Immunol., December 15, 1999; 163(12): 6907 - 6911. [Abstract] [Full Text] [PDF]